C

Cancer and Hematology Centers Of Western Michigan | CHCWM East - Grand Rapids, MI

Research site
(Unclaimed)
Location
5800 Foremost Drive, Grand Rapids, Michigan, United States of America
Site insights

Top conditions

Breast Cancer (6 trials)

Lung Cancer (4 trials)

Leukemia (3 trials)

Non-Small-Cell Lung Carcinoma (3 trials)

Acute Myeloid Leukemia (3 trials)

Top treatments

Nivolumab
Doxorubicin
Vincristine
Cyclophosphamide
Irinotecan
Prednisone
Sacituzumab
Leucovorin
Ipilimumab
Atezolizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

13 of 29
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis (PACIFICA)

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) thera...

Enrolling
Post-essential Thrombocythemia Myelofibrosis
Post-polycythemia Vera Myelofibrosis
Drug: Physician's Choice medications
Drug: Pacritinib

The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of...

Enrolling
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Drug: Pemetrexed
Drug: LY3537982

The purpose of this study is to assess the efficacy and safety of MK-5684 plus hormone replacement therapy (HRT) compared to alternative abiraterone...

Enrolling
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Prostatic Neoplasms
Drug: Enzalutamide
Drug: Hydrocortisone

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

This study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy. The study...

Enrolling
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Doxorubicin
Drug: Prednisone/Prednisolone
Locations recently updated

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously u...

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Vincristine

The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to ful...

Enrolling
Metastatic Breast Cancer
Drug: Lasofoxifene in combination with abemaciclib
Drug: Fulvestrant in combination with abemaciclib

This 2-part study intends to define the recommended Phase 2 dose of ifinatamab deruxtecan (I-DXd) based on the efficacy, safety, and pharmacokinetics...

Enrolling
Extensive-stage Small-cell Lung Cancer
Drug: Ifinatamab Deruxtecan (I-DXd)

The purpose of this study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug combination of...

Active, not recruiting
Biliary Tract Cancer
Drug: Nanoliposomal-Irinotecan
Drug: 5-Fluorouracil

The primary objectives in the dose escalation phase are to evaluate safety and pharmacokinetics (PK) in order to determine the selected dose level(s)...

Active, not recruiting
Malignancies
Drug: cemiplimab
Drug: REGN3767

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surg...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

This is a first-in-human, multi-center, open-label clinical study with separate dose escalation (Phase 1) and expansion (Phase 2) stages to assess pr...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Relapsed/Refractory Multiple Myeloma (RRMM)
Drug: ASTX727
Drug: Dexamethasone

This is a Phase III, global, multicenter, open-label, randomized study to compare the efficacy and safety of 16 cycles (1 cycle duration=21 days) of...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Gemcitabine
Drug: Pemetrexed

Trial sponsors

Celgene logo

Celgene (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems